Related Experiment Video
Updated: Aug 7, 2026

Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
Published on: May 16, 2019
Plasma zinc and growth status in preadolescent children with cystic fibrosis
Asim Maqbool1, Joan I Schall, Babette S Zemel
1Divisions of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. maqbool@email.chop.edu
Insights
Plasma zinc levels and intake were adequate in children with cystic fibrosis (CF) and pancreatic insufficiency (PI). Zinc was not a limiting factor for their suboptimal growth or mild-to-moderate lung disease.
Area of Science:
- Pediatric Nutrition
- Micronutrient Status
- Cystic Fibrosis Research
Background:
- Children with cystic fibrosis (CF) and pancreatic insufficiency (PI) may have altered micronutrient status due to malabsorption.
- Zinc is essential for growth and immune function, and its status in CF patients requires investigation.
Purpose of the Study:
- To assess plasma zinc status in relation to dietary intake, growth, and pulmonary function in preadolescent children with CF and PI.
- To determine if zinc deficiency contributes to suboptimal growth in this population.
Main Methods:
- Assessed fasting plasma zinc, dietary and supplemental zinc intake over 7 days in children aged 8-11 years with CF and PI.
- Measured serum alkaline phosphatase, albumin, pulmonary function (spirometry), coefficient of fat absorption, and growth parameters (AHAZ, WAZ, BMIZ).
Main Results:
- Mean plasma zinc was adequate, with 65% above the reference range; no subjects had low zinc levels.
- Total daily zinc intake was significantly higher than recommended dietary allowances (279%).
- Plasma zinc showed a positive correlation with serum albumin and an inverse correlation with fat malabsorption, but not with growth or pulmonary status.
Conclusions:
- Current care in CF centers ensures adequate zinc intake and plasma zinc status in preadolescent children with CF and PI.
- Zinc is unlikely to be a limiting micronutrient for the suboptimal growth observed in these children with mild-to-moderate lung disease.
Objective:
To investigate plasma zinc status in relation to dietary and supplemental zinc intake, growth and pulmonary status in preadolescent children with cystic fibrosis (CF) and pancreatic insufficiency (PI).
Methods:
Fasting plasma zinc was assessed in children (age, 8-11 years) with CF and PI. Food (7-day weighed records) and supplemental zinc intake, serum alkaline phosphatase and albumin, pulmonary function (spirometry), coefficient of fat absorption (%COA, 72-hour fecal fat) and growth status [height adjusted for genetic potential (AHAZ), weight (WAZ) and BMI Z scores (BMIZ)] were assessed.
Results:
For the 62 children (32 males), mean plasma zinc (+/-SD) was 16.8 +/- 3.1 micromol/L (110 +/- 20 ug/dL). Sixty-five percent of the subjects had levels above the study reference range of 9.2 to 15.3 micromol/L (60-100 ug/dL); no subjects had low zinc levels. Median (range) total daily zinc intake was 279% (83-988%) recommended dietary allowance, growth status was suboptimal (mean +/- SD: AHAZ, -0.8 +/- 1.0; WAZ, -0.5 +/- 1.2; BMIZ, -0.2 +/- 1.1), and forced expiratory volume at 1 second (FEV1) was 92 +/- 13% predicted. Plasma zinc was not correlated with growth, pulmonary or alkaline phosphatase status. Plasma zinc was correlated with serum albumin (r = 0.25, P < 0.05) and was inversely correlated with coefficient of fat absorption (as %; r = -0.30, P = 0.02).
Conclusions:
Under current patterns of care in CF Centers, total zinc intake and plasma zinc status were adequate. These findings suggest that zinc was not a limiting micronutrient for preadolescent children with CF and PI and mild-to-moderate lung disease, and not likely contributing to their suboptimal growth status.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Nature and Nurture
